Western Galilee, Israel

Orit Edelbaum


Average Co-Inventor Count = 8.0

ph-index = 1

Forward Citations = 3(Granted Patents)


Company Filing History:

goldMedal1 out of 832,912 
Other
 patents

Years Active: 2003

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Orit Edelbaum: Innovator in Recombinant Vaccines

Introduction

Orit Edelbaum is a prominent inventor based in Western Galilee, Israel. She has made significant contributions to the field of biotechnology, particularly in the development of recombinant vaccines. Her innovative work focuses on providing effective solutions for viral diseases.

Latest Patents

Orit Edelbaum holds a patent for recombinant vaccines against Infectious Bursal Disease Virus (IBDV). This patent describes a stable vaccine that offers protection against the disease by utilizing viral proteins that are transgenically expressed in plant cells. The invention also includes a method of vaccination that involves administering plant cells containing these viral proteins to animals in need of vaccination. Additionally, the patent outlines a cloning method for viral protein and coding sequences, which can be used to create an expression system for vaccination purposes.

Career Highlights

Throughout her career, Orit Edelbaum has demonstrated a commitment to advancing vaccine technology. Her work has the potential to improve animal health and contribute to the agricultural sector by providing effective vaccination methods against viral diseases.

Collaborations

Orit has collaborated with notable colleagues in her field, including Yehuda Stram and Arie Rogel. These partnerships have enhanced her research and contributed to the success of her innovative projects.

Conclusion

Orit Edelbaum is a trailblazer in the development of recombinant vaccines, with a focus on innovative methods that utilize plant cells for vaccination. Her contributions to biotechnology are paving the way for advancements in disease protection and animal health.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…